08:30        Registration, Partnering Meetings & Networking in the Exhibition Hall

08:55        Opening Remarks
                      Samuel Lagercrantz, Editor-in-chief, Life Science Sweden
                      Lars Frelin, Associate Professor and Director of Education, Karolinska Institutet

09:00        Welcome & Introduction
                      Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

09:05        Enabling and Intensifying Manufacturing of Biologics
                      Véronique Chotteau, Professor in Mammalian Cell-Based Bioprocess Technology, KTH Royal Institute of Technology

09:30        Engaging Ecosystems to Translate ATMPs From Bench to Bedside: Keeping an Eye on Commercialisation and Reimbursement
                      Heather Main, Principle Consultant and Co-founder, HOYA Consulting

09:55        In-House Development of a Protein-Based Biological Drug: A Next-Generation Botulinum Neuromodulator Product for the Aesthetic Market
                      Ulf Ståhl, Product Research Leader, Galderma

10:20        Coffee, Partnering Meetings & Networking in the Exhibition Hall

10:50        BRIDGE Sweden – Accelerating Biologics Development through National Collaboration
                      Alexandra Patriksson, Senior Manager, Testa Center
                      Klas Bratteby, Research Specialist, Karolinska Institutet
                      Niklas Berndt Thalén, Research Scientist, Drug Discovery and Development Platform, SciLifeLab Solna

11:15        Navigating Adeno-Associated Virus Manufacturing Challenges through Analytical and Process Advances
                      Marco Radukic, Research Scientist, Bielefeld University

11:40        Karolinska ATMP Centre: Accelerating Translational Research into Clinical Application
                      Ewa C S Ellis, ATMP Coordinator, Karolinska ATMP Center, Karolinska Institutet

12:05        Lunch, Partnering Meetings & Networking in the Exhibition Hall

12:50        Introducing Cell and Gene Therapies in Sweden – the Role of the New Therapies Council
                      Åsa Derolf, Chair of the New Therapies Council (NT-rådet)

13:15        The Price of Innovation: How Do We Ensure Access to Gene Therapy?
                      – New payment models are needed for life-changing rare disease therapies
                      Fredrik Sjöö, Head of Medical Affairs, Nordic Region, CSL Behring

13:40        Immune Checkpoint Induction by a Topical Oligonucleotide Therapy for Atopic Dermatitis
                      Anna-Lena Spetz, Chief Scientific Officer, TIRmed Pharma

14:05        Coffee, Partnering Meetings & Networking in the Exhibition Hall

14:30        CAR-T Cells – Swedish Experiences
                      Gunilla Enblad, Professor in Oncology, Uppsala University

14:55        Transplantation of Allogeneic Beta Cells with No Immunosuppression
                      Per-Ola Carlsson, Professor in Medical Cell Biology, Uppsala University

15:20        To Be Announced
                      Speakers from Cell2Bio announced shortly
 

15:45        Summary & Conclusion
                      Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

16:00        Flemingsberg Science Christmas Party
                      Food and drinks, music and entertainment, and more – included for everyone!
                      Read more and register here.